ReShape Lifesciences Inc [NASDAQ: RSLS] gained 21.15% on the last trading session, reaching $0.46 price per share at the time.
If compared to the average trading volume of 6.74M shares, RSLS reached a trading volume of 122145122 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about ReShape Lifesciences Inc [RSLS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RSLS shares is $58.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RSLS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for ReShape Lifesciences Inc is set at 0.36, with the Price to Sales ratio for RSLS stock in the period of the last 12 months amounting to 0.19.
Trading performance analysis for RSLS stock
ReShape Lifesciences Inc [RSLS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.89. With this latest performance, RSLS shares dropped by -51.67% in over the last four-week period, additionally sinking by -91.56% over the last 6 months – not to mention a drop of -95.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RSLS stock in for the last two-week period is set at 41.57, with the RSI for the last a single of trading hit 44.49, and the three-weeks RSI is set at 38.69 for ReShape Lifesciences Inc [RSLS]. The present Moving Average for the last 50 days of trading for this stock 1.6271, while it was recorded at 0.6480 for the last single week of trading, and 6.1300 for the last 200 days.
ReShape Lifesciences Inc [RSLS]: A deeper dive into fundamental analysis
ReShape Lifesciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.43 and a Current Ratio set at 0.92.
An analysis of Institutional ownership at ReShape Lifesciences Inc [RSLS]
There are presently around $16.64%, or 19.35%% of RSLS stock, in the hands of institutional investors.
